These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9208284)

  • 1. Competition of iron and aluminum for transferrin: the molecular basis for aluminum deposition in iron-overloaded dialysis patients?
    Van Landeghem GF; D'Haese PC; Lamberts LV; De Broe ME
    Exp Nephrol; 1997; 5(3):239-45. PubMed ID: 9208284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex.
    Sakajiri T; Yamamura T; Kikuchi T; Ichimura K; Sawada T; Yajima H
    Biol Trace Elem Res; 2010 Sep; 136(3):279-86. PubMed ID: 19859668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous multiple element detection by particle beam/hollow cathode-optical emission spectroscopy as a tool for metallomic studies: determinations of metal binding with apo-transferrin.
    Quarles CD; Brumaghim JL; Marcus RK
    Metallomics; 2010 Feb; 2(2):154-61. PubMed ID: 21069147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding affinity of aluminium to human serum transferrin and effects of carbohydrate chain modification as studied by HPLC/high-resolution ICP-MS--speciation of aluminium in human serum.
    Nagaoka MH; Maitani T
    J Inorg Biochem; 2005 Sep; 99(9):1887-94. PubMed ID: 16139893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies on the removal of iron and aluminum from recombinant and site-directed mutant N-lobe half transferrins.
    Li Y; Harris WR; Maxwell A; MacGillivray RT; Brown T
    Biochemistry; 1998 Oct; 37(40):14157-66. PubMed ID: 9760252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a model of non-equilibrium binding of metal ions in biological systems.
    Beardmore J; Exley C
    J Inorg Biochem; 2009 Feb; 103(2):205-9. PubMed ID: 19013648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titanium preferential binding sites in human serum transferrin at physiological concentrations.
    Nuevo-Ordoñez Y; Montes-Bayón M; Blanco González E; Sanz-Medel A
    Metallomics; 2011 Dec; 3(12):1297-303. PubMed ID: 22041858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum uptake and effects on transferrin mediated iron uptake in primary cultures of rat neurons, astrocytes and oligodendrocytes.
    Golub MS; Han B; Keen CL
    Neurotoxicology; 1999 Dec; 20(6):961-70. PubMed ID: 10693977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal retention in human transferrin: consequences of solvent composition in analytical sample preparation methods.
    Quarles CD; Randunu KM; Brumaghim JL; Marcus RK
    Metallomics; 2011 Oct; 3(10):1027-34. PubMed ID: 21904748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin-bound and transferrin free iron uptake by cultured rat astrocytes.
    Qian ZM; Liao QK; To Y; Ke Y; Tsoi YK; Wang GF; Ho KP
    Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):541-8. PubMed ID: 10872741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding patterns of co-existing aluminium and iron to human serum transferrin studied by HPLC-high resolution ICP-MS.
    Nagaoka MH; Maitani T
    Analyst; 2000 Nov; 125(11):1962-5. PubMed ID: 11193083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS.
    Nagaoka MH; Akiyama H; Maitani T
    Analyst; 2004 Jan; 129(1):51-4. PubMed ID: 14737583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin.
    Giannetti AM; Halbrooks PJ; Mason AB; Vogt TM; Enns CA; Björkman PJ
    Structure; 2005 Nov; 13(11):1613-23. PubMed ID: 16271884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of iron-related metabolic parameters in the eye of three animal species.
    Vázquez-Quiñones LE; García-Castiñeiras S
    P R Health Sci J; 2007 Dec; 26(4):373-83. PubMed ID: 18246966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mass spectrometric and molecular modelling study of cisplatin binding to transferrin.
    Khalaila I; Allardyce CS; Verma CS; Dyson PJ
    Chembiochem; 2005 Oct; 6(10):1788-95. PubMed ID: 16196027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative binding study of aluminum and chromium to human transferrin. Effect of iron.
    Moshtaghie AA; Ani M; Bazrafshan MR
    Biol Trace Elem Res; 1992; 32():39-46. PubMed ID: 1375080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the mechanism of action of nitrogen monoxide on iron uptake from transferrin.
    Watts RN; Richardson DR
    J Lab Clin Med; 2000 Aug; 136(2):149-56. PubMed ID: 10945243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable isotope labelling and FPLC-ICP-SFMS for the accurate determination of clinical iron status parameters in human serum.
    del Castillo Busto ME; Montes-Bayón M; Bettmer J; Sanz-Medel A
    Analyst; 2008 Mar; 133(3):379-84. PubMed ID: 18299753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum aluminum transport and aluminum uptake in chronic renal failure: role of iron and aluminum metabolism.
    Cannata JB; Olaizola IR; Gomez-Alonso C; Menéndez-Fraga P; Alonso-Suarez M; Diaz-Lopez JB
    Nephron; 1993; 65(1):141-6. PubMed ID: 8413773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.